Working… Menu

Immune Modulators for Treating COVID-19 (ACTIV-1 IM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04593940
Recruitment Status : Recruiting
First Posted : October 20, 2020
Last Update Posted : June 14, 2021
National Center for Advancing Translational Science (NCATS)
Biomedical Advanced Research and Development Authority
Information provided by (Responsible Party):
Daniel Benjamin, Duke University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 2021
Estimated Study Completion Date : September 2021